Raluca Maria Fostea (Raluca Fostea)

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 2

Top Topics

Positive Breast Cancer

Top Venues

JCO precision oncology

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Elisa Fontana, Gonzalo Torga, Raluca Maria Fostea, Susan Cleator, Ernesto Wasserman, Anastasia Murat, Hendrick-Tobias Arkenau
Sustained Tumor Regression With Zenocutuzumab, a Bispecific Antibody Targeting Human Epidermal Growth Factor Receptor 2/Human Epidermal Growth Factor Receptor 3 Signaling, in NRG1 Fusion-Positive, Estrogen Receptor-Positive Breast Cancer After Progression on a Cyclin-Dependent Kinase 4/6 Inhibitor. JCO precision oncology 6 (2022)
Raluca Maria Fostea, Hendrik-Tobias Arkenau
Trifluridine/tipiracil in the treatment of gastric cancer. Future oncology (London, England) 18 (12) (2022)